Evidence map›Paper›PMID 42388097›Full record

ArticleKorean journal of radiology2026

Transarterial Radioembolization Versus Transarterial Chemoembolization in Elderly Patients (≥75 Years) With Hepatocellular Carcinoma: A Propensity Score-Matched Comparison.

Chan Yang Cho, Gun Ha Kim, Eunbyeol Ko, Jeongyeon Kim, Changhwan Sung, Jin Hyoung Kim, Dong Il Gwon

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Korean journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chan Yang ChoDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-4223-0432
Gun Ha KimDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. kimgh.rad@amc.seoul.kr.ORCID https://orcid.org/0000-0001-5042-1637
Eunbyeol KoDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.ORCID https://orcid.org/0009-0002-3080-0941
Jeongyeon KimDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.ORCID https://orcid.org/0009-0005-6426-5918
Changhwan SungDepartment of Nuclear Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-3590-155X
Jin Hyoung KimDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-7300-6396
Dong Il GwonDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-3121-2853

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the efficacy and safety of transarterial radioembolization (TARE) with those of transarterial chemoembolization (TACE) in elderly patients (≥75 years) with hepatocellular carcinoma (HCC). MATERIALS AND

methodsThis retrospective study included 319 treatment-naïve elderly patients (≥75 years) with HCC who underwent TARE (n = 55) or TACE (n = 264) between November 2021 and November 2025. Propensity score matching (1:1) was performed to balance the baseline characteristics, yielding 55 matched patient pairs. The treatment response, time to local tumor progression (TTLTP), time to progression (TTP), overall survival (OS), adverse events, and length of hospital stay were compared.

resultsAfter matching, the baseline characteristics were well balanced between the two groups. The complete response rate was marginally higher in the TARE group (54.5% vs. 34.5%,

conclusionIn elderly patients with HCC, TARE demonstrated a more favorable safety profile and better local tumor control, in a population enriched with patients typically considered for this procedure in clinical practice. Therefore, TARE may be preferentially considered over TACE for elderly patients with larger tumors or reduced physiological reserves.

Indexed as

Carcinoma, HepatocellularChemoembolization, TherapeuticLiver NeoplasmsRadioembolization, TherapeuticAgedAged, 80 and overFemaleHumansMalePropensity ScoreRetrospective StudiesTreatment OutcomeAgedEfficacyHepatocellular carcinomaProgressionResponseSafetySurvivalTransarterial chemoembolizationTransarterial radioembolizationTreatment outcomes

Identifiers

PMID42388097
PMCPMC13333227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.